Elevated Serum Sialyl Lewis X-i Antigen Levels in Non-Small Cell Lung Cancer with Lung Metastasis

Respiration ◽  
1998 ◽  
Vol 65 (4) ◽  
pp. 295-298 ◽  
Author(s):  
Hiroaki Satoh ◽  
Hiroichi Ishikawa ◽  
Hiroshi Kamma ◽  
Yuko T. Yamashita ◽  
Hideto Takahashi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Lung Metastasis ◽  
Cell Lung Cancer ◽  
Elevated Serum ◽  
Small Cell ◽  
Sialyl Lewis X ◽  
Small Cell Lung ◽  
Lewis X ◽  
Sialyl Lewis

Preoperative serum value of sialyl Lewis X predicts pathological nodal extension and survival in patients with surgically treated small cell lung cancer

2011 ◽  
Vol 105 (8) ◽  
pp. 818-824 ◽  
Author(s):  
Takashi Iwata ◽  
Noritoshi Nishiyama ◽  
Koshi Nagano ◽  
Nobuhiro Izumi ◽  
Takuma Tsukioka ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Sialyl Lewis X ◽  
Small Cell Lung ◽  
Lewis X ◽  
Sialyl Lewis ◽  
Preoperative Serum

scholarly journals Serum sialyl Lewis X level indicates nodal extension in patients with clinical stage 1A non-small cell lung cancer

2010 ◽  
Vol 24 (6) ◽  
pp. 886-890
Author(s):  
Takuma Tsukioka ◽  
Noritoshi Nishiyama ◽  
Takashi Iwata ◽  
Koshi Nagano ◽  
Nobuhiro Izumi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Clinical Stage ◽  
Small Cell ◽  
Sialyl Lewis X ◽  
Small Cell Lung ◽  
Lewis X ◽  
Sialyl Lewis

Clinical Value of Serum Cytokeratin 19 Fragment and Sialyl-Lewis X in Non-Small Cell Lung Cancer

2007 ◽  
Vol 83 (1) ◽  
pp. 216-221 ◽  
Author(s):  
Shinjiro Mizuguchi ◽  
Noritoshi Nishiyama ◽  
Takashi Iwata ◽  
Tatsuya Nishida ◽  
Nobuhiro Izumi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Sialyl Lewis X ◽  
Cytokeratin 19 ◽  
Small Cell Lung ◽  
Clinical Value ◽  
Sialyl Lewis ◽  
Cytokeratin 19 Fragment

scholarly journals Sialyl Lewis X as a predictor of skip N2 metastasis in clinical stage IA non-small cell lung cancer

2013 ◽  
Vol 11 (1) ◽  
pp. 309 ◽  
Author(s):  
Hiroaki Komatsu ◽  
Shinjiro Mizuguchi ◽  
Nobuhiro Izumi ◽  
Kyukwang Chung ◽  
Shoji Hanada ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Clinical Stage ◽  
Small Cell ◽  
Sialyl Lewis X ◽  
Small Cell Lung ◽  
Clinical Stage Ia ◽  
Sialyl Lewis ◽  
Stage Ia

scholarly journals Amrubicin therapy improves patients with refractory small-cell lung cancer: A single-arm confirmatory Chinese clinical study

2016 ◽  
Vol 11 (3) ◽  
pp. 564
Author(s):  
Mengli Zheng ◽  
Naikang Zhou ◽  
Lianjun Ma ◽  
Wenbo Jin
Keyword(s):  
Lung Cancer ◽  
Clinical Study ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Elevated Serum ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Serum Transaminases ◽  
Rate Of Response

<p class="Abstract">Our objective was to evaluate an open-label, multicenter, single-arm study to appraise whether amrubicin therapy improves patients with refractory small-cell lung cancer in Chinese clinical study. Patients (n=95) with refractory small-cell lung cancer received 3 consecutive days amrubicin therapy for 21 days. Overall response rate of response to amrubicin was 39%. Anemia, febrile neutropenia, thrombocytopenia, hyperglycemia, hyponatremia, infection, elevated serum transaminases levels were appeared, but the incidences of adverse events were very few. Our results suggest amrubicin therapy can improve patients with refractory small-cell lung cancer and may be an effective and safe treatment option.</p><p> </p>

Sign in / Sign up

Export Citation Format

Share Document